Affiliation:
1. Anastats, Rowan Lodge, Olde Fairfield, Bourton, Dorset, SP8 5YG, UK.
Abstract
Background: The acceptance criteria for chromatographic bioassays are generally based upon the specifications found in the US FDA Guidance for Industry document, whereas regression analysis is a statistical process and, thus, most suited to large data populations, rather than the small populations used in assay calibration. Data that form part of the statistical population are often excluded in order that calibrations meet these acceptance criteria. Results/discussion: Monte Carlo simulations of various linear regression calibration strategies, which take into account guidance acceptance criteria, have been used to quantify calibration errors. Conclusion: It is concluded that 1/x2 weighting generally produces results that meet both theoretical and regulatory requirements, and that use of single, rather than duplicate, calibrators can result in misleading statistics at the LLOQ.
Subject
Medical Laboratory Technology,Clinical Biochemistry,General Pharmacology, Toxicology and Pharmaceutics,General Medicine,Analytical Chemistry
Reference7 articles.
1. US Food and Drug Administration.Guidance for Industry: Bioanalytical Method Validation.US Department of Health and Human Services, FDA, Center for Drug Evaluation and Research, Rockville, MD, USA (2001).
2. Error estimates on normal least squares linear regression with replicate injection of calibration standards
3. Evaluation of calibration routines in pharmaceutical and bioanalytical separations, with reference to Monte Carlo simulations
4. Analytical Methods Committee.Amc Technical Brief AMCTB No. 27. Thompson M (Ed.). Royal Society of Chemistry, London, UK,1–2 (2007).
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献